Screener
Integra LifeSciences IART Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Integra LifeSciences in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableTradeCurrent.
The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000917520-26-000058
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Current portion of borrowings under senior credit facility | $43,594 | $38,750 |
| Current portion of borrowings under securitization facility | — | 87,800 |
| Current portion of lease liability - operating leases | 13,920 | 14,019 |
| Accounts payable, trade | 82,637 | 95,726 |
| Contract liabilities | 11,699 | 11,463 |
| Income tax payable | 3,236 | 3,651 |
| Accrued compensation | 68,177 | 74,079 |
| Accrued expenses and other current liabilities | 107,618 | 130,493 |
Item 1. Financial Statements
FAQ
- What is Integra LifeSciences's accounts payable?
- Integra LifeSciences (IART) reported accounts payable of $82.64M in Q2 2026.
- How has Integra LifeSciences's accounts payable changed year-over-year?
- Integra LifeSciences's accounts payable decreased by 11.0% year-over-year, from $92.84M to $82.64M.
- What is the long-term trend for Integra LifeSciences's accounts payable?
- Over 5 years (2020 to 2025), Integra LifeSciences's accounts payable has grown at a 11.9% compound annual growth rate (CAGR), from $54.61M to $95.73M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Integra LifeSciences's accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude